SPERLING SCOTT M 4

What Happened

• Scott M. Sperling, a member of Thermo Fisher Scientific's Board of Directors, was credited with 82.84 deferred stock units on June 27, 2026. The units were valued at $513.03 each (total ≈ $42,499) under the company's Deferred Compensation Plan for Directors. This was an award/crediting of director compensation (derivative stock units), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-27; Form 4 filed: 2026-06-30 (appears timely).
• Units credited: 82.84 deferred stock units; unit price used: $513.03; implied value ≈ $42,499.
• Transaction code: A (award/other acquisition via deferred compensation).
• Shares owned after transaction: not disclosed in this filing.
• Footnotes:
  • F1: Units are convertible into common stock on a 1-for-1 basis.
  • F2: These are stock units credited under the Directors' Deferred Compensation Plan; directors' retainers are deferred quarterly into stock units based on quarter-end closing price. Units are distributable as stock upon cessation of director service or a change of control.
• This is a routine director compensation credit (derivative award), not an immediate market trade — it does not indicate a purchase or sale of shares at market.

Context

• Deferred stock units represent a right to receive shares later (convertible 1-for-1) and are commonly used for director compensation; they should be viewed as payroll/compensation rather than a direct insider buy/sell signal.